anmelden
SMI Expanded
1.967,59
PKT
+1,12
PKT
+0,06
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 23.03.21 | DocMorris buy | Warburg Research | |
| 23.03.21 | Novartis buy | Jefferies & Company Inc. | |
| 23.03.21 | Novartis market-perform | Bernstein Research | |
| 23.03.21 | Roche Outperform | Bernstein Research | |
| 23.03.21 | UBS kaufen | DZ BANK | |
| 23.03.21 | Roche Neutral | UBS AG | |
| 23.03.21 | Roche Hold | Deutsche Bank AG | |
| 23.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.03.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.03.21 | Roche overweight | Barclays Capital | |
| 22.03.21 | Novartis market-perform | Bernstein Research | |
| 22.03.21 | Roche Neutral | UBS AG | |
| 22.03.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 22.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 19.03.21 | Holcim overweight | JP Morgan Chase & Co. | |
| 19.03.21 | DocMorris Sell | UBS AG | |
| 19.03.21 | DocMorris overweight | Barclays Capital | |
| 18.03.21 | UBS overweight | JP Morgan Chase & Co. | |
| 18.03.21 | DocMorris Sell | UBS AG | |
| 18.03.21 | DocMorris overweight | Barclays Capital | |
| 18.03.21 | DocMorris buy | Warburg Research | |
| 18.03.21 | DocMorris buy | Baader Bank | |
| 18.03.21 | DocMorris buy | Jefferies & Company Inc. | |
| 18.03.21 | Nestlé overweight | JP Morgan Chase & Co. | |
| 17.03.21 | UBS Neutral | UBS AG | |
| 17.03.21 | UBS Hold | Kepler Cheuvreux | |
| 17.03.21 | Nestlé overweight | Morgan Stanley | |
| 17.03.21 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 16.03.21 | UBS Outperform | Credit Suisse Group | |
| 16.03.21 | UBS Sector Perform | RBC Capital Markets | |
| 16.03.21 | UBS overweight | JP Morgan Chase & Co. | |
| 16.03.21 | Roche Hold | Jefferies & Company Inc. | |
| 15.03.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.03.21 | Roche Neutral | UBS AG | |
| 15.03.21 | DocMorris buy | Jefferies & Company Inc. | |
| 12.03.21 | Swiss Re overweight | Barclays Capital | |
| 12.03.21 | ams-OSRAM Underweight | Barclays Capital | |
| 12.03.21 | UBS Neutral | Goldman Sachs Group Inc. | |
| 11.03.21 | Givaudan Underperform | Bernstein Research |